(Q54565355)

English

Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR - a comparison with immunohistochemical and FISH results.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR - a comparison with immunohistochemical and FISH results (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

immunohistochemistry

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Anna-Maria Tokes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Pál Kaposi-Novák

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Nóra Udvarhelyi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Anikó Keller

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Zsuzsa Schaff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

25 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Pathology and Oncology Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

197-204

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17189981%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

describes a project that uses

immunohistochemistry

1 reference

based on heuristic

inferred from title

Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis

1 reference

https://api.crossref.org/works/10.1007%2FBF02893412

21 January 2018

p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion

1 reference

https://api.crossref.org/works/10.1007%2FBF02893412

21 January 2018

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu (c-erb-B2) gene and protein in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[HER-2 diagnostics]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating HER2 amplification and overexpression in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: comparison of results and correlation with survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/17189981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54565355&oldid=2212519810"